MedPath

Mebendazole compared with secnidazole-adult giardiasis-Phase III

Phase 3
Completed
Conditions
Giardiasis
Registration Number
RPCEC00000095
Lead Sponsor
Central Military Hospital Carlos J. Finlay
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
110
Inclusion Criteria

Informed-consent form signed. Patients with 18 years and older.

Exclusion Criteria

Patients who had previously received any antiparasitic drug within 1 month before entering the study. Have known about any hypersensitivity to any of the drugs in use. Have any immunodeficiency disease. Have any hepatic disease. Have any renal disease. Have any cardiovascular disease. Have any haematological disease. Have used other drugs joined to the drugs in use. Women were pregnant or lactation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.